Loading....

Tell Novo Nordisk and Sanofi to Lower Insulin Prices

The U.S. insulin market is dominated by three companies: Eli Lilly, Novo Nordisk, and Sanofi.

Eli Lilly recently announced that it will reduce the price of some forms of insulin it sells.

Public Citizen is calling on Novo Nordisk and Sanofi to follow Eli Lilly and finally move toward putting lives before (even more) profits by reducing the price of their insulin products.

To Novo Nordisk and Sanofi

Over one million Americans with diabetes ration their insulin because of Big Pharma’s price gouging. Eli Lilly has made the overdue decision to lower the price of some of its insulin products. You should, at the very least, do the same.

ADD YOUR NAME

First Name

Last Name

Email Address*

Zip Code

222 - Subtopic - U.S. Drug Prices & Global Access to Medicines

Yes No

SUBMIT

© 2021 Public Citizen. This web site is shared by Public Citizen Inc. and Public Citizen Foundation.
Learn more about the distinction between these two components of Public Citizen.

Tell Novo Nordisk and Sanofi to Lower Insulin Prices

To Novo Nordisk and Sanofi

ADD YOUR NAME

Thank You For Taking Action to Stop the Koch Network from Co-opting Universities